| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymorphism, Single Nucleotide | 45 | 2021 | 1079 | 2.770 |
Why?
|
| Asthma | 29 | 2013 | 397 | 2.580 |
Why?
|
| DNA Methylation | 9 | 2020 | 130 | 1.950 |
Why?
|
| Genetic Predisposition to Disease | 28 | 2020 | 836 | 1.620 |
Why?
|
| Polymorphism, Genetic | 19 | 2011 | 196 | 1.510 |
Why?
|
| Fatty Acid Desaturases | 7 | 2020 | 44 | 1.400 |
Why?
|
| Genome-Wide Association Study | 18 | 2021 | 543 | 1.320 |
Why?
|
| Occupational Exposure | 10 | 2018 | 224 | 1.140 |
Why?
|
| Hispanic Americans | 18 | 2020 | 904 | 1.030 |
Why?
|
| Chromosome Mapping | 15 | 2020 | 190 | 0.930 |
Why?
|
| Bronchial Hyperreactivity | 10 | 2011 | 22 | 0.900 |
Why?
|
| European Continental Ancestry Group | 21 | 2020 | 1131 | 0.890 |
Why?
|
| Pesticides | 6 | 2017 | 189 | 0.810 |
Why?
|
| Epigenesis, Genetic | 6 | 2020 | 98 | 0.800 |
Why?
|
| Humans | 108 | 2021 | 29093 | 0.800 |
Why?
|
| Agriculture | 7 | 2018 | 174 | 0.740 |
Why?
|
| African Continental Ancestry Group | 8 | 2021 | 350 | 0.730 |
Why?
|
| Female | 78 | 2021 | 18164 | 0.700 |
Why?
|
| Occupational Diseases | 2 | 2016 | 83 | 0.650 |
Why?
|
| Adult | 48 | 2020 | 8420 | 0.640 |
Why?
|
| Male | 70 | 2021 | 17807 | 0.630 |
Why?
|
| Immunoglobulin E | 9 | 2011 | 47 | 0.620 |
Why?
|
| Genotype | 26 | 2018 | 735 | 0.610 |
Why?
|
| Hypersensitivity | 4 | 2004 | 25 | 0.600 |
Why?
|
| Interleukin-13 | 4 | 2010 | 33 | 0.600 |
Why?
|
| Alleles | 13 | 2018 | 251 | 0.590 |
Why?
|
| Emigrants and Immigrants | 7 | 2020 | 235 | 0.560 |
Why?
|
| Seasons | 1 | 2016 | 84 | 0.560 |
Why?
|
| Soybean Proteins | 2 | 2016 | 64 | 0.540 |
Why?
|
| Cardiovascular Diseases | 6 | 2019 | 1013 | 0.520 |
Why?
|
| Receptors, Estrogen | 6 | 2016 | 89 | 0.520 |
Why?
|
| Linkage Disequilibrium | 11 | 2014 | 192 | 0.510 |
Why?
|
| Middle Aged | 42 | 2020 | 10829 | 0.510 |
Why?
|
| Quantitative Trait Loci | 6 | 2020 | 140 | 0.510 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2020 | 145 | 0.500 |
Why?
|
| Multigene Family | 4 | 2018 | 47 | 0.490 |
Why?
|
| Monocytes | 4 | 2021 | 119 | 0.480 |
Why?
|
| DiGeorge Syndrome | 5 | 2012 | 11 | 0.480 |
Why?
|
| Obesity | 5 | 2020 | 1063 | 0.460 |
Why?
|
| Estrogen Replacement Therapy | 5 | 2010 | 182 | 0.460 |
Why?
|
| Proteins | 6 | 2020 | 140 | 0.460 |
Why?
|
| Genetic Variation | 5 | 2017 | 251 | 0.460 |
Why?
|
| Promoter Regions, Genetic | 8 | 2011 | 212 | 0.460 |
Why?
|
| Atherosclerosis | 6 | 2018 | 693 | 0.460 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 200 | 0.450 |
Why?
|
| African Americans | 11 | 2021 | 1373 | 0.430 |
Why?
|
| Phenotype | 17 | 2012 | 629 | 0.430 |
Why?
|
| Genome, Human | 4 | 2020 | 129 | 0.420 |
Why?
|
| Butyrylcholinesterase | 2 | 2017 | 15 | 0.420 |
Why?
|
| Haplotypes | 9 | 2016 | 220 | 0.420 |
Why?
|
| Transcription Factors | 4 | 2011 | 172 | 0.410 |
Why?
|
| DNA | 6 | 2020 | 204 | 0.410 |
Why?
|
| Gene Expression | 6 | 2021 | 332 | 0.400 |
Why?
|
| Case-Control Studies | 15 | 2017 | 859 | 0.400 |
Why?
|
| Receptors, Interleukin-4 | 4 | 2010 | 6 | 0.400 |
Why?
|
| Adolescent | 22 | 2020 | 3254 | 0.390 |
Why?
|
| Cognition Disorders | 5 | 2019 | 390 | 0.390 |
Why?
|
| Organophosphorus Compounds | 1 | 2010 | 35 | 0.370 |
Why?
|
| Metabolomics | 2 | 2020 | 45 | 0.360 |
Why?
|
| Coronary Artery Disease | 5 | 2018 | 359 | 0.360 |
Why?
|
| Genomics | 2 | 2020 | 82 | 0.360 |
Why?
|
| Proteomics | 3 | 2019 | 92 | 0.350 |
Why?
|
| Caspase 10 | 1 | 2008 | 1 | 0.340 |
Why?
|
| Caspase 8 | 1 | 2008 | 9 | 0.340 |
Why?
|
| North Carolina | 10 | 2020 | 1423 | 0.340 |
Why?
|
| Fungicides, Industrial | 2 | 2018 | 9 | 0.310 |
Why?
|
| Pyrethrins | 2 | 2018 | 12 | 0.310 |
Why?
|
| Insecticides | 2 | 2018 | 21 | 0.310 |
Why?
|
| Stroke | 3 | 2010 | 545 | 0.310 |
Why?
|
| Hypersensitivity, Immediate | 3 | 2002 | 9 | 0.310 |
Why?
|
| Child | 20 | 2020 | 2219 | 0.310 |
Why?
|
| Gene Frequency | 9 | 2013 | 225 | 0.300 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2018 | 32 | 0.300 |
Why?
|
| Metalloendopeptidases | 2 | 2004 | 11 | 0.300 |
Why?
|
| American Native Continental Ancestry Group | 2 | 2017 | 13 | 0.300 |
Why?
|
| Postmenopause | 6 | 2009 | 397 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2005 | 5 | 0.290 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2009 | 37 | 0.290 |
Why?
|
| Cholesterol, HDL | 4 | 2011 | 165 | 0.290 |
Why?
|
| Hormone Replacement Therapy | 2 | 2003 | 86 | 0.280 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 481 | 0.280 |
Why?
|
| Repressor Proteins | 3 | 2017 | 53 | 0.270 |
Why?
|
| Membrane Glycoproteins | 3 | 2018 | 97 | 0.270 |
Why?
|
| Forced Expiratory Volume | 6 | 2013 | 112 | 0.270 |
Why?
|
| Transients and Migrants | 4 | 2018 | 281 | 0.270 |
Why?
|
| Aorta | 2 | 2018 | 103 | 0.270 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2020 | 37 | 0.270 |
Why?
|
| Netherlands | 9 | 2010 | 21 | 0.270 |
Why?
|
| Antigens, Differentiation | 2 | 2002 | 21 | 0.260 |
Why?
|
| Immunoconjugates | 2 | 2002 | 9 | 0.260 |
Why?
|
| Abnormalities, Multiple | 2 | 2012 | 24 | 0.260 |
Why?
|
| Aged | 22 | 2020 | 9487 | 0.250 |
Why?
|
| Aortic Diseases | 2 | 2018 | 54 | 0.250 |
Why?
|
| Body Height | 2 | 2021 | 30 | 0.250 |
Why?
|
| Coronary Disease | 4 | 2010 | 200 | 0.250 |
Why?
|
| Nicotine | 2 | 2017 | 157 | 0.250 |
Why?
|
| Vital Capacity | 4 | 2013 | 44 | 0.240 |
Why?
|
| Brain Ischemia | 1 | 2005 | 136 | 0.240 |
Why?
|
| Muscles | 2 | 2011 | 53 | 0.240 |
Why?
|
| Young Adult | 10 | 2020 | 2402 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2002 | 9 | 0.240 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 72 | 0.230 |
Why?
|
| Animals | 13 | 2021 | 7297 | 0.230 |
Why?
|
| Brain | 3 | 2017 | 930 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2012 | 20 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2015 | 1379 | 0.220 |
Why?
|
| Genetic Markers | 6 | 2001 | 122 | 0.220 |
Why?
|
| Prostatic Neoplasms | 2 | 2018 | 441 | 0.220 |
Why?
|
| Mutation | 6 | 2009 | 466 | 0.220 |
Why?
|
| HLA Antigens | 2 | 2017 | 35 | 0.210 |
Why?
|
| CpG Islands | 3 | 2017 | 44 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 326 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 20 | 3 | 1999 | 6 | 0.210 |
Why?
|
| Macaca fascicularis | 4 | 2021 | 389 | 0.210 |
Why?
|
| Cholesterol | 2 | 2015 | 229 | 0.210 |
Why?
|
| Epistasis, Genetic | 1 | 2001 | 44 | 0.210 |
Why?
|
| Cotinine | 3 | 2017 | 45 | 0.200 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 148 | 0.200 |
Why?
|
| Diet, Mediterranean | 1 | 2021 | 23 | 0.200 |
Why?
|
| Organ Specificity | 2 | 2018 | 77 | 0.200 |
Why?
|
| Social Behavior | 1 | 2021 | 67 | 0.200 |
Why?
|
| Interferons | 1 | 2020 | 17 | 0.190 |
Why?
|
| Catechol O-Methyltransferase | 3 | 2012 | 14 | 0.190 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 142 | 0.190 |
Why?
|
| Acrocephalosyndactylia | 2 | 1998 | 3 | 0.190 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 35 | 0.190 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2017 | 23 | 0.190 |
Why?
|
| Estrogen Receptor alpha | 5 | 2010 | 50 | 0.190 |
Why?
|
| Nuclear Proteins | 2 | 1998 | 71 | 0.180 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 100 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 980 | 0.180 |
Why?
|
| Inflammation | 2 | 2021 | 507 | 0.180 |
Why?
|
| Membrane Proteins | 3 | 2012 | 256 | 0.180 |
Why?
|
| DNA Primers | 3 | 2009 | 87 | 0.180 |
Why?
|
| Liver | 2 | 2014 | 464 | 0.180 |
Why?
|
| Risk Factors | 10 | 2013 | 3531 | 0.180 |
Why?
|
| Pedigree | 8 | 2014 | 133 | 0.180 |
Why?
|
| Tobacco | 2 | 2020 | 50 | 0.180 |
Why?
|
| Lung | 3 | 2013 | 233 | 0.180 |
Why?
|
| Glucose | 1 | 2020 | 163 | 0.180 |
Why?
|
| Attitude to Health | 1 | 2020 | 148 | 0.170 |
Why?
|
| Point Mutation | 1 | 1999 | 23 | 0.170 |
Why?
|
| Odds Ratio | 5 | 2016 | 447 | 0.170 |
Why?
|
| Whole-Body Irradiation | 1 | 2019 | 48 | 0.170 |
Why?
|
| NAD | 1 | 2018 | 25 | 0.170 |
Why?
|
| Diastole | 1 | 2018 | 90 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 57 | 0.160 |
Why?
|
| Ovariectomy | 1 | 2018 | 147 | 0.160 |
Why?
|
| Base Sequence | 8 | 2020 | 240 | 0.160 |
Why?
|
| Saliva | 1 | 2018 | 36 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 5 | 2016 | 172 | 0.160 |
Why?
|
| Homeostasis | 1 | 2018 | 127 | 0.160 |
Why?
|
| Ellis-Van Creveld Syndrome | 1 | 1997 | 1 | 0.160 |
Why?
|
| Nails, Malformed | 1 | 1997 | 1 | 0.160 |
Why?
|
| Tooth Abnormalities | 1 | 1997 | 1 | 0.160 |
Why?
|
| Polydactyly | 1 | 1997 | 1 | 0.160 |
Why?
|
| Dwarfism | 1 | 1997 | 3 | 0.160 |
Why?
|
| Leukocytes | 1 | 2018 | 52 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1997 | 10 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 47 | 0.160 |
Why?
|
| Estradiol | 1 | 2018 | 118 | 0.160 |
Why?
|
| Carbamates | 1 | 2018 | 14 | 0.160 |
Why?
|
| Genes, Dominant | 1 | 1997 | 26 | 0.160 |
Why?
|
| DNA Mutational Analysis | 6 | 2014 | 67 | 0.160 |
Why?
|
| Genetic Load | 1 | 2017 | 4 | 0.160 |
Why?
|
| Thiocarbamates | 1 | 2017 | 6 | 0.160 |
Why?
|
| Adipose Tissue | 1 | 2020 | 327 | 0.150 |
Why?
|
| Heart | 1 | 2018 | 161 | 0.150 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 298 | 0.150 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 1997 | 1 | 0.150 |
Why?
|
| Exons | 4 | 2005 | 49 | 0.150 |
Why?
|
| Heredity | 1 | 2017 | 12 | 0.150 |
Why?
|
| Genes | 1 | 2017 | 15 | 0.150 |
Why?
|
| Coronary Vessels | 1 | 2018 | 147 | 0.150 |
Why?
|
| Stress, Psychological | 1 | 2019 | 208 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 65 | 0.150 |
Why?
|
| DNA, Intergenic | 2 | 2020 | 9 | 0.150 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 226 | 0.150 |
Why?
|
| Calcium | 1 | 2018 | 296 | 0.150 |
Why?
|
| Molecular Sequence Data | 9 | 2004 | 350 | 0.150 |
Why?
|
| Phosphofructokinase-1 | 1 | 1996 | 1 | 0.140 |
Why?
|
| Autoimmune Diseases | 2 | 2012 | 50 | 0.140 |
Why?
|
| Ethnic Groups | 3 | 2013 | 440 | 0.140 |
Why?
|
| Sexual Maturation | 1 | 2016 | 26 | 0.140 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 9 | 0.140 |
Why?
|
| Germ-Line Mutation | 1 | 2015 | 17 | 0.140 |
Why?
|
| Asbestos | 1 | 2015 | 8 | 0.140 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 46 | 0.140 |
Why?
|
| Smoking | 3 | 2015 | 427 | 0.140 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2015 | 7 | 0.140 |
Why?
|
| Mesothelioma | 1 | 2015 | 38 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 39 | 0.130 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2014 | 1 | 0.130 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2014 | 4 | 0.130 |
Why?
|
| HLA-DQ Antigens | 2 | 2016 | 9 | 0.130 |
Why?
|
| Lod Score | 7 | 2005 | 71 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2012 | 28 | 0.130 |
Why?
|
| Learning | 1 | 2015 | 76 | 0.130 |
Why?
|
| Eicosanoids | 1 | 2014 | 7 | 0.130 |
Why?
|
| alpha-Linolenic Acid | 1 | 2014 | 11 | 0.130 |
Why?
|
| United States | 9 | 2020 | 3630 | 0.120 |
Why?
|
| DNA, Satellite | 1 | 1994 | 1 | 0.120 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2014 | 29 | 0.120 |
Why?
|
| Estrogens | 3 | 2006 | 162 | 0.120 |
Why?
|
| Genetic Testing | 6 | 2009 | 90 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2014 | 35 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 5 | 4 | 2009 | 15 | 0.120 |
Why?
|
| Cerebral Hemorrhage | 1 | 2014 | 62 | 0.120 |
Why?
|
| C-Reactive Protein | 2 | 2007 | 232 | 0.120 |
Why?
|
| Computational Biology | 3 | 2020 | 86 | 0.120 |
Why?
|
| Fixatives | 1 | 2013 | 3 | 0.120 |
Why?
|
| Paraffin | 1 | 2013 | 4 | 0.120 |
Why?
|
| Paraffin Embedding | 1 | 2013 | 10 | 0.120 |
Why?
|
| Formaldehyde | 1 | 2013 | 11 | 0.120 |
Why?
|
| Th1 Cells | 1 | 2013 | 18 | 0.110 |
Why?
|
| Forestry | 1 | 2013 | 4 | 0.110 |
Why?
|
| STAT4 Transcription Factor | 3 | 2020 | 16 | 0.110 |
Why?
|
| Skin Tests | 2 | 2003 | 15 | 0.110 |
Why?
|
| Mothers | 1 | 2013 | 79 | 0.110 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 2 | 2016 | 14 | 0.110 |
Why?
|
| Corpus Callosum | 1 | 2012 | 13 | 0.110 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2012 | 13 | 0.110 |
Why?
|
| Schizophrenic Psychology | 1 | 2012 | 15 | 0.110 |
Why?
|
| Genes, Recessive | 3 | 2002 | 9 | 0.110 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 40 | 0.110 |
Why?
|
| Schizophrenia | 1 | 2012 | 38 | 0.110 |
Why?
|
| Genes, Homeobox | 1 | 2011 | 3 | 0.100 |
Why?
|
| Patient Selection | 1 | 2013 | 257 | 0.100 |
Why?
|
| Caseins | 1 | 2011 | 13 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 384 | 0.100 |
Why?
|
| Anxiety Disorders | 1 | 2012 | 60 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2013 | 154 | 0.100 |
Why?
|
| Isoflavones | 1 | 2011 | 65 | 0.100 |
Why?
|
| Cohort Studies | 5 | 2015 | 1687 | 0.100 |
Why?
|
| Saint Kitts and Nevis | 1 | 2011 | 3 | 0.100 |
Why?
|
| Body Weights and Measures | 1 | 2011 | 22 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 45 | 0.100 |
Why?
|
| Genome | 2 | 2002 | 40 | 0.100 |
Why?
|
| Respiratory Tract Diseases | 1 | 2011 | 30 | 0.100 |
Why?
|
| Calcinosis | 1 | 2011 | 143 | 0.100 |
Why?
|
| Venous Thromboembolism | 1 | 2010 | 25 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2011 | 52 | 0.090 |
Why?
|
| Risk | 3 | 2008 | 289 | 0.090 |
Why?
|
| Rhinitis | 1 | 2010 | 11 | 0.090 |
Why?
|
| Monkey Diseases | 1 | 2010 | 18 | 0.090 |
Why?
|
| Blood Glucose | 2 | 2010 | 466 | 0.090 |
Why?
|
| Multifactorial Inheritance | 2 | 2017 | 19 | 0.090 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2010 | 6 | 0.090 |
Why?
|
| HLA-DR Antigens | 1 | 2010 | 8 | 0.090 |
Why?
|
| DNA Repair Enzymes | 1 | 2010 | 16 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2011 | 131 | 0.090 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2011 | 86 | 0.090 |
Why?
|
| Models, Genetic | 3 | 2005 | 92 | 0.090 |
Why?
|
| Interviews as Topic | 3 | 2017 | 249 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2013 | 865 | 0.090 |
Why?
|
| Receptor, Endothelin B | 1 | 2009 | 5 | 0.090 |
Why?
|
| Endothelin-1 | 1 | 2009 | 17 | 0.090 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 74 | 0.090 |
Why?
|
| Central America | 2 | 2020 | 5 | 0.090 |
Why?
|
| Regression Analysis | 2 | 2017 | 274 | 0.090 |
Why?
|
| Lipoproteins | 1 | 2009 | 82 | 0.090 |
Why?
|
| Chromosomes, Artificial, Yeast | 3 | 1999 | 6 | 0.090 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2008 | 1 | 0.080 |
Why?
|
| Anxiety | 1 | 2010 | 159 | 0.080 |
Why?
|
| Migraine Disorders | 1 | 2009 | 58 | 0.080 |
Why?
|
| Bronchial Provocation Tests | 1 | 2008 | 14 | 0.080 |
Why?
|
| Introns | 2 | 2005 | 39 | 0.080 |
Why?
|
| Mexico | 2 | 2020 | 63 | 0.080 |
Why?
|
| Aging | 3 | 2004 | 881 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2015 | 3717 | 0.080 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2008 | 6 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2008 | 6 | 0.080 |
Why?
|
| Ventricular Fibrillation | 1 | 2008 | 4 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 1 | 2008 | 14 | 0.080 |
Why?
|
| Diet | 2 | 2016 | 354 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2008 | 36 | 0.080 |
Why?
|
| Insulin | 1 | 2010 | 346 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 412 | 0.080 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 1998 | 3 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2008 | 59 | 0.080 |
Why?
|
| ADAM Proteins | 2 | 2004 | 13 | 0.080 |
Why?
|
| Albuminuria | 1 | 2008 | 176 | 0.070 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2006 | 6 | 0.070 |
Why?
|
| Logistic Models | 3 | 2017 | 727 | 0.070 |
Why?
|
| Time Factors | 3 | 2019 | 2001 | 0.070 |
Why?
|
| Chromosomes, Human | 3 | 2002 | 9 | 0.070 |
Why?
|
| Sex Characteristics | 2 | 2004 | 167 | 0.070 |
Why?
|
| Transcriptional Activation | 2 | 2002 | 42 | 0.070 |
Why?
|
| Respiratory Function Tests | 3 | 2013 | 111 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2005 | 64 | 0.070 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2017 | 12 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 3 | 2017 | 139 | 0.070 |
Why?
|
| Autopsy | 2 | 2018 | 37 | 0.070 |
Why?
|
| Chloride Channels | 1 | 2004 | 7 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2005 | 116 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2004 | 58 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2002 | 100 | 0.060 |
Why?
|
| Population Groups | 1 | 2004 | 7 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2004 | 23 | 0.060 |
Why?
|
| Continental Population Groups | 2 | 2008 | 221 | 0.060 |
Why?
|
| Africa | 2 | 2021 | 23 | 0.060 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2004 | 8 | 0.060 |
Why?
|
| Interleukin-4 | 1 | 2004 | 20 | 0.060 |
Why?
|
| Age of Onset | 2 | 2017 | 95 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2004 | 45 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 2017 | 72 | 0.060 |
Why?
|
| Europe | 2 | 2021 | 77 | 0.060 |
Why?
|
| Genetic Heterogeneity | 2 | 2001 | 13 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2003 | 464 | 0.060 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2020 | 47 | 0.060 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2003 | 6 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2017 | 1167 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 2003 | 27 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2002 | 13 | 0.050 |
Why?
|
| Factor V | 1 | 2002 | 6 | 0.050 |
Why?
|
| Triglycerides | 3 | 2010 | 214 | 0.050 |
Why?
|
| E-Selectin | 1 | 2002 | 20 | 0.050 |
Why?
|
| Thromboembolism | 1 | 2002 | 30 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 48 | 0.050 |
Why?
|
| Genetic Loci | 2 | 2013 | 147 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 519 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 2108 | 0.050 |
Why?
|
| Research Design | 1 | 2003 | 286 | 0.050 |
Why?
|
| Probability | 2 | 2017 | 150 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2000 | 15 | 0.050 |
Why?
|
| Age Factors | 2 | 2017 | 1108 | 0.050 |
Why?
|
| Heterocyclic Compounds | 1 | 2020 | 8 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2020 | 16 | 0.050 |
Why?
|
| Isoquinolines | 1 | 2020 | 6 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 16 | 0.050 |
Why?
|
| Protein Array Analysis | 1 | 2020 | 16 | 0.050 |
Why?
|
| Smoke | 1 | 2020 | 12 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2020 | 35 | 0.050 |
Why?
|
| Linear Models | 2 | 2013 | 426 | 0.050 |
Why?
|
| Organ Size | 2 | 2012 | 196 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2020 | 67 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 69 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 1999 | 8 | 0.050 |
Why?
|
| Executive Function | 2 | 2010 | 54 | 0.050 |
Why?
|
| DNA Replication | 1 | 2000 | 23 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2012 | 17 | 0.040 |
Why?
|
| Chromosome Deletion | 2 | 2012 | 9 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2019 | 14 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 1996 | 37 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 1999 | 7 | 0.040 |
Why?
|
| Fluorescence | 1 | 1999 | 21 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 1998 | 598 | 0.040 |
Why?
|
| Acrylamides | 1 | 2018 | 4 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2010 | 379 | 0.040 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2018 | 12 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2018 | 28 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 136 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 91 | 0.040 |
Why?
|
| Tretinoin | 1 | 2018 | 34 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2018 | 24 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 1218 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 213 | 0.040 |
Why?
|
| MSX1 Transcription Factor | 1 | 1997 | 1 | 0.040 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 1997 | 4 | 0.040 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1997 | 7 | 0.040 |
Why?
|
| Transfection | 1 | 2018 | 192 | 0.040 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2017 | 3 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 2017 | 4 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2019 | 322 | 0.040 |
Why?
|
| High Mobility Group Proteins | 1 | 2017 | 7 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2018 | 92 | 0.040 |
Why?
|
| Dinucleotide Repeats | 1 | 1997 | 1 | 0.040 |
Why?
|
| Receptors, Thyrotropin | 1 | 1997 | 2 | 0.040 |
Why?
|
| Sex Factors | 3 | 2007 | 631 | 0.040 |
Why?
|
| Syndrome | 1 | 1997 | 66 | 0.040 |
Why?
|
| Thyroid Diseases | 1 | 1997 | 6 | 0.040 |
Why?
|
| Myocardium | 1 | 2018 | 170 | 0.040 |
Why?
|
| Infant | 2 | 2017 | 969 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 1997 | 50 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 2017 | 14 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2017 | 36 | 0.040 |
Why?
|
| Acetylcholinesterase | 1 | 2017 | 17 | 0.040 |
Why?
|
| Demography | 1 | 2017 | 104 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 72 | 0.040 |
Why?
|
| Piperidines | 1 | 2018 | 125 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2020 | 449 | 0.040 |
Why?
|
| Asian Continental Ancestry Group | 1 | 1997 | 110 | 0.040 |
Why?
|
| Bone and Bones | 1 | 1997 | 87 | 0.040 |
Why?
|
| Blood | 1 | 2017 | 8 | 0.040 |
Why?
|
| Foot Deformities, Congenital | 1 | 1997 | 1 | 0.040 |
Why?
|
| Rest | 1 | 2017 | 49 | 0.040 |
Why?
|
| Dipeptides | 1 | 1997 | 9 | 0.040 |
Why?
|
| Lipids | 1 | 2018 | 209 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 89 | 0.040 |
Why?
|
| Hand Deformities, Congenital | 1 | 1997 | 7 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1997 | 18 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 67 | 0.040 |
Why?
|
| Cytokines | 1 | 2018 | 243 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2013 | 454 | 0.040 |
Why?
|
| Awareness | 1 | 2017 | 28 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2017 | 97 | 0.040 |
Why?
|
| Mitochondria | 1 | 2018 | 174 | 0.040 |
Why?
|
| Prevalence | 2 | 2011 | 896 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 1999 | 726 | 0.040 |
Why?
|
| Mexican Americans | 1 | 2017 | 59 | 0.040 |
Why?
|
| Restriction Mapping | 1 | 1996 | 9 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 1996 | 21 | 0.040 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2016 | 4 | 0.040 |
Why?
|
| Argentina | 1 | 2016 | 5 | 0.040 |
Why?
|
| Chile | 1 | 2016 | 6 | 0.040 |
Why?
|
| Cholinesterases | 1 | 2016 | 10 | 0.040 |
Why?
|
| beta Karyopherins | 1 | 2016 | 7 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2016 | 8 | 0.040 |
Why?
|
| Oxygen | 1 | 2017 | 139 | 0.040 |
Why?
|
| Peru | 1 | 2016 | 19 | 0.040 |
Why?
|
| Interferon Regulatory Factors | 1 | 2016 | 12 | 0.040 |
Why?
|
| Phytoestrogens | 1 | 2016 | 16 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2017 | 134 | 0.040 |
Why?
|
| Craniosynostoses | 1 | 1997 | 59 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2017 | 163 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 60 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 680 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2018 | 573 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2015 | 48 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 155 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2015 | 34 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2017 | 3111 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 863 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 242 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 1995 | 8 | 0.030 |
Why?
|
| Radiography | 2 | 2011 | 353 | 0.030 |
Why?
|
| Occupational Health | 1 | 2015 | 77 | 0.030 |
Why?
|
| Leukotriene B4 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Linoleic Acid | 1 | 2014 | 14 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 20 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2014 | 35 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2011 | 1305 | 0.030 |
Why?
|
| Medically Underserved Area | 1 | 2013 | 22 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 10 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 101 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2016 | 436 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 18 | 0.030 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2013 | 10 | 0.030 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 105 | 0.030 |
Why?
|
| Fisheries | 1 | 2013 | 4 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2013 | 26 | 0.030 |
Why?
|
| Neoplasms | 1 | 2019 | 610 | 0.030 |
Why?
|
| Family | 2 | 2005 | 105 | 0.030 |
Why?
|
| Southeastern United States | 1 | 2013 | 71 | 0.030 |
Why?
|
| Cheek | 1 | 2012 | 5 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2012 | 16 | 0.030 |
Why?
|
| Mouth Mucosa | 1 | 2012 | 29 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2012 | 3 | 0.030 |
Why?
|
| Psychopathology | 1 | 2012 | 5 | 0.030 |
Why?
|
| Asian Americans | 1 | 2013 | 98 | 0.030 |
Why?
|
| Weight Loss | 1 | 2015 | 413 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 67 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 320 | 0.030 |
Why?
|
| Reference Values | 1 | 2012 | 224 | 0.030 |
Why?
|
| Thrombospondins | 1 | 2011 | 7 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2012 | 225 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2011 | 26 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2011 | 16 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2011 | 10 | 0.020 |
Why?
|
| Estrogen Receptor beta | 1 | 2010 | 12 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2004 | 18 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 1994 | 366 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 90 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 72 | 0.020 |
Why?
|
| Methionine | 1 | 2010 | 7 | 0.020 |
Why?
|
| Valine | 1 | 2010 | 17 | 0.020 |
Why?
|
| Amyloidosis | 1 | 2010 | 10 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2010 | 92 | 0.020 |
Why?
|
| Cerebellum | 1 | 2010 | 29 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2010 | 22 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2010 | 45 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 709 | 0.020 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2009 | 11 | 0.020 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2009 | 12 | 0.020 |
Why?
|
| Lipoprotein Lipase | 1 | 2009 | 14 | 0.020 |
Why?
|
| Attention | 1 | 2010 | 83 | 0.020 |
Why?
|
| Lipase | 1 | 2009 | 28 | 0.020 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2009 | 89 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2009 | 60 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 462 | 0.020 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2009 | 125 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 145 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 666 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 562 | 0.020 |
Why?
|
| Memory | 1 | 2010 | 187 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 93 | 0.020 |
Why?
|
| Mice | 2 | 2004 | 2368 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2006 | 3 | 0.020 |
Why?
|
| Medroxyprogesterone | 1 | 2006 | 12 | 0.020 |
Why?
|
| Intelligence | 1 | 2006 | 5 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 273 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2004 | 10 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 2004 | 19 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 35 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 23 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 43 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 1356 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 103 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 449 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 92 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 160 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 171 | 0.010 |
Why?
|
| Allergens | 1 | 2002 | 16 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2002 | 92 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2004 | 720 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 572 | 0.010 |
Why?
|
| Eosinophils | 1 | 2002 | 48 | 0.010 |
Why?
|
| Cognition | 1 | 2006 | 526 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2001 | 11 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2001 | 15 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 129 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2003 | 711 | 0.010 |
Why?
|
| Christianity | 1 | 2000 | 5 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2000 | 15 | 0.010 |
Why?
|
| Chromosomes, Bacterial | 1 | 1999 | 1 | 0.010 |
Why?
|
| Contig Mapping | 1 | 1999 | 3 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1999 | 5 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1999 | 7 | 0.010 |
Why?
|
| Hypertension | 1 | 2007 | 906 | 0.010 |
Why?
|
| Family Health | 1 | 2000 | 78 | 0.010 |
Why?
|
| Software | 1 | 1999 | 109 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 3099 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 73 | 0.010 |
Why?
|
| Thyroiditis | 1 | 1997 | 1 | 0.010 |
Why?
|
| Myxedema | 1 | 1997 | 3 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1997 | 7 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 280 | 0.010 |
Why?
|
| Japan | 1 | 1997 | 15 | 0.010 |
Why?
|
| Graves Disease | 1 | 1997 | 4 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 1997 | 18 | 0.010 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 1997 | 3 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 1997 | 12 | 0.010 |
Why?
|
| Heterozygote | 1 | 1997 | 52 | 0.010 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1997 | 4 | 0.010 |
Why?
|
| Serine | 1 | 1997 | 11 | 0.010 |
Why?
|
| Proline | 1 | 1997 | 10 | 0.010 |
Why?
|
| Nucleotides | 1 | 1997 | 16 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1997 | 12 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2001 | 2019 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 1997 | 195 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1995 | 9 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1995 | 10 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1995 | 20 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1995 | 63 | 0.010 |
Why?
|